Physician

Amar Oza, M.D.

According to 2025 Medicare claims, Amar Oza, M.D. (NPI: 1316207277) practices rheumatology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is BUFFALO RHEUMATOLOGY AND MEDICINE PLLC (NPI: 1013027663) and primary practice location at 14226-2783.

Oza's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 481 traditional Medicare patients, billed 102,615 HCPCS/CPT codes, and received $1,700,571 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,858 prescription claims across 778 beneficiaries totaling $8,375,378 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 47 records totaling $1,032. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $25,001 to $1,700,571. Similarly, Part D prescription costs have moved sharply higher in recent years, from $13,276 to $8,375,378. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$897K$1.8M2017 Medicare payment: $25,001 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $157,584 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $358,609 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,143,886 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,628,484 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,330,975 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,794,888 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,700,571 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017118355$25,001
20182547,884$157,584
201921925,465$358,609
202035266,300$1,143,886
202142388,152$1,628,484
202242383,072$1,330,975
202346390,520$1,794,888
2024481102,615$1,700,571

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.2M$8.4M2015 Drug cost: $13,276 (USD; Tot_Drug_Cst)2016 Drug cost: $68,849 (USD; Tot_Drug_Cst)2017 Drug cost: $97,801 (USD; Tot_Drug_Cst)2018 Drug cost: $304,094 (USD; Tot_Drug_Cst)2019 Drug cost: $1,785,536 (USD; Tot_Drug_Cst)2020 Drug cost: $2,385,821 (USD; Tot_Drug_Cst)2021 Drug cost: $4,401,971 (USD; Tot_Drug_Cst)2022 Drug cost: $5,859,071 (USD; Tot_Drug_Cst)2023 Drug cost: $7,285,713 (USD; Tot_Drug_Cst)2024 Drug cost: $8,375,378 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201557619$13,276
201660270$68,849
201778383$97,801
2018194718$304,094
20193171,908$1,785,536
20204002,955$2,385,821
20215223,894$4,401,971
20225874,162$5,859,071
20237115,001$7,285,713
20247785,858$8,375,378

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more244343$92
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less83207$49
J0897Injection, denosumab, 1 mg13512,540$20
96372Injection of drug or substance under skin or into muscle148297$12
J7050Infusion, normal saline solution, 250 cc111367$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1424,564$1,441,205
Orencia ClickjectAbatacept1044,200$871,304
Xeljanz XrTofacitinib Citrate1043,780$721,858
Enbrel SureclickEtanercept511,988$513,741
Taltz AutoinjectorIxekizumab591,932$493,580

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.47$1,032ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amar Oza, M.D.?

Tedicare shows public-source Medicare data for Amar Oza, M.D. (NPI 1316207277), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amar Oza, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amar Oza, M.D.?

Amar Oza, M.D. is linked to BUFFALO RHEUMATOLOGY AND MEDICINE PLLC (billing NPI 1013027663) in the available physician profile data.

Does Amar Oza, M.D. have Open Payments data?

Amar Oza, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.